CFTR and cystic fibrosis: In the present study, we demonstrated that CRMS/CFSPID subjects carrying the D1152H variant in trans with a mutation classified as caused by CFTR2 had a more severe expression during the follow-up and a higher risk to evolve in CFTR-RD and CF.